SCYNEXIS INC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SCYNEXIS, Inc. on May 18, 2021, reporting events that occurred on May 17, 2021. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol SCYX.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a corporate financing event.
Material Changes
On May 17, 2021, SCYNEXIS entered into Controlled Equity Offering SM Sales Agreements with Cantor Fitzgerald & Co. and Ladenburg Thalmann & Co. Inc. (the "Agents"). Key terms include:
- Offering Size: The company may sell up to an aggregate of $50 million of its Common Stock.
- Method: Sales will be made "at-the-market" under an effective Form S-3 registration statement.
- Compensation: Agents will receive 3.0% of the gross sales price of shares sold.
- Obligation: SCYNEXIS is not obligated to sell any shares under these agreements.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on operational outlook, or specific risk factors beyond standard securities law disclaimers. The offering will terminate upon the sale of all shares or the termination of the Sales Agreements by either party.
Investor Verification Checklist
- Verify the current share price to assess potential dilution if the full $50 million is sold.
- Review the attached Sales Agreements (Exhibits 1.1 and 1.2) for specific termination rights and conditions.
- Monitor future filings to determine if and when shares are actually sold under this program.
- Check the company's cash position in the most recent 10-Q or 10-K to understand the necessity of this financing option.